InvestorsHub Logo
icon url

biosectinvestor

05/09/24 5:04 AM

#689904 RE: The Danish Dude #689903

It really doesn’t have to be deduced. The University has said so clearly when it refers to ATL-DC trials as DCVax-L and same with Dr. Liau. Even this paper says it is licensed to NWBO, clearly indicating it is DCVax-L. But so long as there is a generic reference and these fraudsters can get away with intentionally sowing confusion, they will do so, because for them, such activity is plausibly deniable and profitable.
icon url

Dox_Dox

05/09/24 7:57 AM

#689926 RE: The Danish Dude #689903

Ok. So where are the Institutional Investors? Or the analysts? Why only retail who think they are smarter than all the research arms of small, medium, and big pharma? What if someone serious in retail was thinking of buying this- what timeframe would you give them for NWBO to be profitable? You are talking years and years. If you mention BO- great. But get in line with hugely profitable small and medium bios already taking in money. Every one of their investors hopes for a BuyOut. Stats? How many companies on average get BO every year? How many already this year?
Now lastly- how good do you feel recommending this company to a new investor based on management’s track record & the keeping Sharehodlers abreast of due discourse?
icon url

TTsr

05/09/24 8:27 AM

#689936 RE: The Danish Dude #689903

Well put Danish Dude… as one poster wrote yesterday, we INEXORABLY move forward✌🏻
icon url

Legend431

05/10/24 1:24 PM

#690356 RE: The Danish Dude #689903

Yeah and the preprint and the actual article really moved that stock up 1 or 2 cents. Be prepared for the same once approval happens or a big slide if it doesn’t. Happy pumping Friday to you dud